Nicole Campbell, Ph.D.
Postdoctoral Scientist
Centre for Innate Immunity and Infectious Diseases
Hudson Institute of Medical Research
Clayton Australia
Dr. Nicole Campbell completed her Ph.D. in Immunology under the supervision of Dr. Aisling Dunne at Trinity College Dublin (Ireland) in 2018. Her Ph.D. research focused on the anti-inflammatory functions of the enzyme heme oxygenase 1 (HO-1), through which she published one of the first characterisations of human dendritic cell immunometabolism, and identified a novel relationship between metabolic signalling and immunoregulation via HO-1. In January 2019 she commenced a postdoctoral research position with Prof Paul Hertzog at the Hudson Institute of Medical Research in Melbourne, Australia. Her current research is centered on interferon epsilon; a unique type I interferon discovered by Prof Hertzog’s lab, which is constitutively expressed under hormonal control in the female reproductive tract. Dr. Campbell leads efforts within Prof Hertzog’s lab to characterise the anti-tumour potential of interferon epsilon, and its immunoregulatory role within the peritoneal cavity.